AMGN · AMGEN Inc
United States · RS rating 96 · As of 2026-10-14
| Price | 426.11 USD |
|---|---|
| 1-day change | +3.2% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 95 / 89 / 89 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 49 / 55 / 55 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -58.7% |
| Sales growth Q/Q | +3.2% |
| Distance from 52-week high | +4.1% |
| Market cap (USD) | $187.9B |